BioNxt Solutions Inc. (FRA:BXT)

Market Cap	41.12M
Revenue (ttm)	27.88K
Net Income (ttm)	-4.30M
Shares Out	n/a
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	19,013
Average Volume	18,128
Open	0.3330
Previous Close	0.3560
Day's Range	0.3330 - 0.3780
52-Week Range	0.1200 - 0.4050
Beta	n/a
RSI	60.95
Earnings Date	Jun 2, 2025

About BioNxt Solutions

BioNxt Solutions Inc. engages in R&D and manufacturing of thin-film (sublingual) and skin patch (transdermal) drug delivery for neurological and autoimmune diseases, enhancing patient compliance and bioavailability. It offers diagnostic screening tests, and new active pharmaceutical production and evaluation, including precision transdermal and oral dissolvable drug formulations; oral health screening tests; and standardization and clinical evaluation of emerging active pharmaceutical ingredients for neurological applications. The company was f...

• Industry: Pharmaceutical Preparations
• Founded: 2017
• Country: Canada
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: BXT

Financial Performance

In 2023, BioNxt Solutions's revenue was 372,247, an increase of 25.15% compared to the previous year's 297,442. Losses were -7.72 million, -37.60% less than in 2022.

Financial numbers in CAD